MicroPort Scientific (FRA:MSK) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MSK MicroPort Scientific Corp FRA:MSK
43 GF Score
Price €0.76
GF Value €0.95
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is MicroPort Scientific Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of MicroPort Scientific is: High Risk: High uncertainty with risk-return tradeoff.

MicroPort Scientific  (FRA:MSK) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

MicroPort Scientific Risk Assessment Related Terms

FRA:MSK vs ABT, SYK, MDT: Risk Assessment Comparison

For the Medical Devices subindustry, MicroPort Scientific's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort Scientific Risk Assessment vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort Scientific's Risk Assessment distribution charts can be found below:

* The bar in red indicates where MicroPort Scientific's Risk Assessment falls into.


FRA:MSK
43GF Score
MicroPort Scientific Corp FRA:MSK
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MicroPort Scientific (FRA:MSK) Overvalued in 2026?

Based on GuruFocus' analysis, MicroPort Scientific stock appears to be undervalued. The current stock price of €0.76 is trading 20.5% below its estimated GF Value™ of €0.95. GuruFocus considers MicroPort Scientific to be Modestly Undervalued.

Key valuation signals for FRA:MSK:

  • Risk Assessment:
  • GF Value™: €0.95 vs. price of €0.76 (20.5% below fair value)
  • GF Score™: 43/100 with 8 warning signs

No single metric tells the full story. See the FRA:MSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MicroPort Scientific Business Description

Other Exchanges MCRPF:USA00853:Hong Kong
Address 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203
MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacturing, & R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacturing, R&D of orthopedics devices. CRM business: sales, manufacturing, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacturing, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacturing, R&D of neurovascular devices. Structural heart disease business: sales, manufacturing, R&D of heart valve devices. Surgical robot business: sales, manufacturing, & R&D of surgical robot devices. Surgical devices business: sales, manufacturing, R&D of surgical devices.
43GF Score

Get the complete analysis for FRA:MSK

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price
€0.95
GF Value